Dizze trije toiletdeteksje sûnenstechnologyen sille klinysk wurde hifke yn 'e FS, Israel en Japan

Dizze trije toiletdeteksje sûnenstechnologyen sille klinysk wurde hifke yn 'e FS, Israel en Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 juny. The technology gains life-saving medical insights by analysing human excrement. It bedriuw hat in searje fan trije patinten yntsjinne dy't eleminten fan har medyske toiletsensor dekke.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Japan en Sina.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, De technology fan OutSense kin de boarne fan bloed by it gastrointestinale traktaat identifisearje.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Neffens OutSense CEO Yfat Scialom, who predicts that “mei de eksploazje fan digitale medisinen, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, inflammatoire darm sykte en urinary traktaat ynfeksjes.

Its solution consists of a multispectral optical sensor, in ljochtboarne en in autonoom screening-apparaat dat in WiFi-ferbining omfettet. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Ynformaasje krigen fan sampled bloed, kombinearre mei ekstra analyze fan 'e tiid fan bloeden oant útskieding, jout details oer de bloedende patology. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense kundige dat CommuniCare, in grut soarchbedriuw mei mear as 90 healthcare facilities in the US, sil dit jier begjinne mei it pilotearjen fan syn technology. Neist dizze pilot, OutSense also plans to conduct clinical trials in Israel and Japan.

Besykje Mear nijs by Viga.cc Nijs